|
Cuenca-Zamora EJ, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Morales ML, Lozano ML, Gonzalez-Conejero R, Martinez C, Teruel-Montoya R, Ferrer-Marin F. miR-146a-/- mice model reveals that NF-kappaB inhibition reverts inflammation-driven myelofibrosis-like phenotype. Am J Hematol. 2024 Jul;99(7):1326-1337. doi: 10.1002/ajh.27322. Epub 2024 Apr 22. PubMed PMID: 38646919.
AÑO: 2024; IF: 10.1
|
38646919
|
Cuenca-Zamora EJ, Martinez C, Morales ML, Guijarro-Carrillo PJ, Lopez-Poveda MJ, Alcolea-Guardiola C, Vidal-Garrido N, Lozano ML, Gonzalez-Conejero R, Teruel-Montoya R, Ferrer-Marin F. Pacritinib prevents inflammation-driven myelofibrosis-like phenotype in a miR-146a-/- murine model. Biomed Pharmacother. 2024 Dec;181:117712. doi: 10.1016/j.biopha.2024.117712. Epub 2024 Nov 26. PubMed PMID: 39603040.
AÑO: 2024; IF: 6.9
|
|
de Los Reyes-Garcia AM, Rivera-Caravaca JM, Zapata-Martinez L, Aguila S, Veliz-Martinez A, Garcia-Barbera N, Gil-Perez P, Guijarro-Carrillo PJ, Orenes-Pinero E, Lopez-Garcia C, Lozano ML, Marin F, Martinez C, Gonzalez-Conejero R. MiR-146a Contributes to Thromboinflammation and Recurrence in Young Patients with Acute Myocardial Infarction. J Pers Med. 2022 Jul 20;12(7):1185. doi: 10.3390/jpm12071185. PubMed PMID: 35887682; PubMed Central PMCID: PMC9318357.
AÑO: 2022; IF: 3.508
|